Begin main content

Search

We found 5757 result(s)

HTAi 2018 Annual Meeting

Event Date: June 1, 2018 - June 5, 2018
Result type: Events

CADTH is pleased to be co-hosting the Health Technology Assessment international (HTAi) 2018 Annual Meeting in Vancouver, British Columbia, June 1 to 5, 2018. Dr. Tammy Clifford, Chief Scientist and Vice-President of Evidence Standards and Medical Devices at CADTH, is a co-chair of the International Scientific Programme Committee. The theme of t...

Annual ARCC Conference: Canada’s Applied Research in Cancer Control Conference

Event Date: May 27, 2018 - May 28, 2018
Result type: Events

The Canadian Centre for Applied Research in Cancer Control (ARCC)’s 7th annual conference will be held May 27 to 28, 2018, at the Hotel Bonaventure in Montreal, Quebec. Dr. Brian O’Rourke, CADTH President and CEO, and Dr. Maureen Trudeau, Chair for the pCODR Expert Review Committee, will be speaking as plenary panelists at this event. The object...

2018 Canadian Association of Emergency Physicians Conference

Event Date: May 26, 2018 - May 30, 2018
Result type: Events

Sarah Garland, CADTH Knowledge Mobilization Officer, will present on CADTH’s Optimal Use project on the optimal strategies for the diagnosis of pulmonary embolism, at the Canadian Association of Emergency Medicine (CAEP) 2018 Conference, Strengthening Connections, being held May 26 to 30, in Calgary, Alberta. Follow @CAEP_Docs and@CAEPConference...

Levodopa / carbidopa (Drug Plan Submission) (Duodopa )

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Levodopa / carbidopa (Drug Plan Submission)
Indications: Parkinson's disease

  • Brand Name: Duodopa
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0557-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Nervous System, Nervous system, Parkinson

Dolutegravir / rilpivirine (Juluca)

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dolutegravir rilpivirine
Indications: HIV infection

  • Brand Name: Juluca
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0551-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV, Human Immunodeficiency Virus Proteins, HIV/AIDS, Infectious diseases, HIV; rilpivirine; dolutegravir; Juluca; human immuno-deficiency virus; Human immunodeficiency virus; human immuno-deficiency viruses; human immunodeficiency viruses

Empagliflozin (Jardiance)

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Empagliflozin
Indications: Diabetes mellitus (Type 2)

  • Brand Name: Jardiance
  • Manufacturer: Boehringer Ingelheim (Canada) Ltd.
  • Project Number: SR0427-000
  • Project Status: Complete
  • Submission Type: Pre-NOC

Tags

Diabetes Mellitus, Type 2, Diabetes

Tiotropium bromide (Spiriva Respimat)

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Tiotropium bromide
Indications: Chronic Obstructive Pulmonary Disease (COPD)

  • Brand Name: Spiriva Respimat
  • Manufacturer: Boehringer Ingelheim (Canada) Ltd.
  • Project Number: SR0412-000
  • Project Status: Complete
  • Submission Type: New

Tags

Pulmonary Disease, Chronic Obstructive, COPD

ledipasvir, sofosbuvir (Harvoni)

Last Updated: May 23, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ledipasvir, sofosbuvir
Indications: Hepatitis C, chronic

  • Brand Name: Harvoni
  • Manufacturer: Gilead Sciences Canada Inc.
  • Project Number: SF0465-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

Tags

Hepatitis C, Hepatitis

lixisenatide + insulin glargine (Soliqua)

Last Updated: May 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: lixisenatide + insulin glargine
Indications: Diabetes mellitus, Type 2

  • Brand Name: Soliqua
  • Manufacturer: sanofi-aventis Canada Inc.
  • Project Number: SR0564-000
  • Project Status: Received
  • Submission Type: NewCombination

Tags

Diabetes

ixekizumab (Taltz)

Last Updated: May 22, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ixekizumab
Indications: Arthritis, psoriatic

  • Brand Name: Taltz
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0558-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Arthritis, Dermatology, Arthritis, Dermatology, Musculoskeletal